PLSH logo

Panacea Life Sciences Holdings OTCPK:PLSH Stock Report

Last Price

US$0.19

Market Cap

US$3.4m

7D

48.0%

1Y

-57.8%

Updated

26 Apr, 2024

Data

Company Financials

Panacea Life Sciences Holdings, Inc.

OTCPK:PLSH Stock Report

Market Cap: US$3.4m

PLSH Stock Overview

Panacea Life Sciences Holdings, Inc., operates as a holding company, manufactures, research, and produces hemp-derived cannabinoid, functional mushroom, kratom, and nutraceutical products for consumers and pets.

PLSH fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Panacea Life Sciences Holdings, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Panacea Life Sciences Holdings
Historical stock prices
Current Share PriceUS$0.19
52 Week HighUS$0.63
52 Week LowUS$0.096
Beta3.32
1 Month Change-3.89%
3 Month Change57.02%
1 Year Change-57.78%
3 Year Changen/a
5 Year Changen/a
Change since IPO-95.01%

Recent News & Updates

Recent updates

Shareholder Returns

PLSHUS PharmaceuticalsUS Market
7D48.0%-0.6%1.0%
1Y-57.8%10.6%21.9%

Return vs Industry: PLSH underperformed the US Pharmaceuticals industry which returned 10.6% over the past year.

Return vs Market: PLSH underperformed the US Market which returned 21.9% over the past year.

Price Volatility

Is PLSH's price volatile compared to industry and market?
PLSH volatility
PLSH Average Weekly Movement59.3%
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: PLSH's share price has been volatile over the past 3 months.

Volatility Over Time: PLSH's weekly volatility has increased from 45% to 59% over the past year.

About the Company

FoundedEmployeesCEOWebsite
200840Leslie Buttorffwww.panacealife.com

Panacea Life Sciences Holdings, Inc., operates as a holding company, manufactures, research, and produces hemp-derived cannabinoid, functional mushroom, kratom, and nutraceutical products for consumers and pets. The company also involved in the white label and contract manufacturing sales to other cannabinoid companies, raw material sales, and tolling arrangements. In addition, it offers natural remedies for aspect of life under the PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life brand name.

Panacea Life Sciences Holdings, Inc. Fundamentals Summary

How do Panacea Life Sciences Holdings's earnings and revenue compare to its market cap?
PLSH fundamental statistics
Market capUS$3.35m
Earnings (TTM)-US$8.02m
Revenue (TTM)US$2.38m

1.4x

P/S Ratio

-0.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PLSH income statement (TTM)
RevenueUS$2.38m
Cost of RevenueUS$6.47m
Gross Profit-US$4.09m
Other ExpensesUS$3.93m
Earnings-US$8.02m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.45
Gross Margin-171.48%
Net Profit Margin-336.08%
Debt/Equity Ratio-186.7%

How did PLSH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.